Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02758691Phase 1Completed
Phase 1, randomised, double-blind trial in Alzheimer's disease (AD) comparing Intranasal Insulin with Saline Placebo (2 arms). Primary endpoint: Change in Memory Recall Performance during functional Magnetic Resonance Imaging task at 1 day. Started Dec 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02758691.